Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 42,000 full-time employees. The firm helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Follow-Up Questions
What is Cencora Inc (COR)'s P/E Ratio?
The P/E ratio of Cencora Inc is 40.7689
Who is the CEO of Cencora Inc?
Dr. Robert Mauch is the President of Cencora Inc, joining the firm since 2015.
What is the price performance of COR stock?
The current price of COR is $340.93, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Cencora Inc?
Cencora Inc belongs to Health Care industry and the sector is Health Care
What is Cencora Inc market cap?
Cencora Inc's current market cap is $66.0B
Is Cencora Inc a buy, sell, or hold?
According to wall street analysts, 17 analysts have made analyst ratings for Cencora Inc, including 5 strong buy, 11 buy, 6 hold, 0 sell, and 5 strong sell
